| 1 |
33755421 | The Interaction of Porcine Dihydropyrimidine Dehydrogenase with the Chemotherapy Sensitizer: 5-Ethynyluracil. | 2021 Apr 13 |
2 |
| 2 |
21344302 | Final results of a prematurely discontinued Phase 1/2 study of eniluracil with escalating doses of 5-fluorouracil administered orally in patients with advanced hepatocellular carcinoma. | 2011 Oct |
2 |
| 3 |
16466986 | A phase I study of eniluracil/5-FU in combination with radiation therapy for potentially resectable and/or unresectable cancer of the pancreas and distal biliary tract. | 2006 Feb |
2 |
| 4 |
12904894 | Dihydropyrimidine dehydrogenase (DPD) rapidly regenerates after inactivation by eniluracil (GW776C85) in primary and metastatic colorectal cancer. | 2003 Nov |
11 |
| 5 |
12006517 | Impact of two weekly schedules of oral eniluracil given with fluorouracil and leucovorin on the duration of dihydropyrimidine dehydrogenase inhibition. | 2002 May |
3 |
| 6 |
12140902 | The effect of dihydropyrimidine dehydrogenase deficiency on outcomes with fluorouracil. | 2002 |
1 |
| 7 |
12448660 | Biochemical modulation of 5-fluorouacil through dihydropyrimidine dehydrogenase inhibition: a Southwest Oncology Group phase II trial of eniluracil and 5-fluorouracil in advanced resistant colorectal cancer. | 2002 Nov |
1 |
| 8 |
11219979 | Oral eniluracil/5-FU for advanced colon and breast carcinomas. | 2001 Jan |
1 |
| 9 |
11283924 | Phase II study of oral eniluracil, 5-fluorouracil, and leucovorin in patients with advanced colorectal carcinoma. | 2001 Apr 1 |
1 |
| 10 |
11459999 | Peripheral neuropathy associated with weekly oral 5-fluorouracil, leucovorin and eniluracil. | 2001 Jul |
3 |
| 11 |
11060767 | Eniluracil: an irreversible inhibitor of dihydropyrimidine dehydrogenase. | 2000 Jul |
5 |
| 12 |
11081572 | Preclinical development of eniluracil: enhancing the therapeutic index and dosing convenience of 5-fluorouracil. | 2000 Nov |
2 |
| 13 |
11081573 | Pharmacology of fluorinated pyrimidines: eniluracil. | 2000 Nov |
2 |
| 14 |
11081574 | Clinical development of eniluracil/fluorouracil: an oral treatment for patients with solid tumors. | 2000 Nov |
4 |
| 15 |
11106122 | Pharmacokinetics and bioequivalence of a combined oral formulation of eniluracil, an inactivator of dihydropyrimidine dehydrogenase, and 5-fluorouracil in patients with advanced solid malignancies. | 2000 Oct |
2 |
| 16 |
10037177 | Phase I study of eniluracil, a dihydropyrimidine dehydrogenase inactivator, and oral 5-fluorouracil with radiation therapy in patients with recurrent or advanced head and neck cancer. | 1999 Feb |
2 |
| 17 |
10561307 | Eniluracil treatment completely inactivates dihydropyrimidine dehydrogenase in colorectal tumors. | 1999 Aug |
3 |
| 18 |
10595802 | Novel oral fluoropyrimidines in the treatment of metastatic colorectal cancer. | 1999 Dec 1 |
2 |
| 19 |
9552051 | Phase I clinical and pharmacologic study of eniluracil plus fluorouracil in patients with advanced cancer. | 1998 Apr |
2 |
| 20 |
9556784 | Improving 5-FU with a novel dihydropyrimidine dehydrogenase inactivator. | 1998 Mar |
2 |
| 21 |
9830627 | Clinical development of eniluracil: current status. | 1998 Oct |
2 |
| 22 |
9264323 | Dual modulation of 5-fluorouracil cytotoxicity using folinic acid with a dihydropyrimidine dehydrogenase inhibitor. | 1997 Jun 1 |
1 |
| 23 |
9816071 | Dihydropyrimidine dehydrogenase: a tumoral target for fluorouracil modulation. | 1995 Sep |
1 |
| 24 |
1544906 | Mechanism-based inactivation of dihydropyrimidine dehydrogenase by 5-ethynyluracil. | 1992 Mar 15 |
5 |